Cvs Health (CVS) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access CVS Annual Income Statement →
The income statement data below highlights shifts in Cvs Health's operating performance over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
Q1 2026
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax62,226.00
Total Revenue100,426.00
Costs & Expenses
Cost of Goods and Services Sold55,444.00
Gross Profit15,624.00
Goodwill, Impairment Loss12.00
Other operatinig exp. /-income11,718.00
Total operating costs including COS95,746.00
Operating income / -loss4,680.00
Net Interest Expense / -Income0.00
Net Investment Income574.00
Other loss/ -income168.00
Total costs & expenses96,488.00
Income & Taxes
Income / -loss before income taxes3,938.00
Income taxes expenses / -benefit981.00
Income after income taxes2,957.00
Income / -loss from continuing operations2,957.00
Non-controlling interests-14.00
Net income / -loss2,957.00
Income / -loss to shareholder2,943.00
EBIT3,938.00
EBITD5,053.00
EBITDA5,053.00
Earnings Per Share
Basic EPS (excl. extra items)2.31
Extraordinary items0.00
Basic Net EPS2.31
Basic shares outstanding (Mill. of Units)1,273.00
Diluted Net EPS2.30
Diluted average shares (Mill. of Units)1,279.00
Dividend per share0.66
4 historic quarters locked

Sign in to unlock the full Cvs Health income statement history.

About Cvs Health Corp Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: August 5, 2026
  • Original filing: cvs-20260630.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.